Mark Espeland to Sensitivity and Specificity
This is a "connection" page, showing publications Mark Espeland has written about Sensitivity and Specificity.
Connection Strength
0.125
-
Espeland MA, Regensteiner JG, Jaramillo SA, Gregg E, Knowler WC, Wagenknecht LE, Bahnson J, Haffner S, Hill J, Hiatt WR. Measurement characteristics of the ankle-brachial index: results from the Action for Health in Diabetes study. Vasc Med. 2008 Aug; 13(3):225-33.
Score: 0.071
-
Woods NF, Cochrane BB, LaCroix AZ, Seguin RA, Zaslavsky O, Liu J, Beasley JM, Brunner RL, Espeland MA, Goveas JS, Lane DS, Manson JE, Mouton CP, Robinson JG, Tinker LF. Toward a positive aging phenotype for older women: observations from the women's health initiative. J Gerontol A Biol Sci Med Sci. 2012 Nov; 67(11):1191-6.
Score: 0.023
-
Bhasin S, Espeland MA, Evans WJ, Ferrucci L, Fried LP, Gill TM, Pahor M, Studenski S, Guralnik J, Nayfield S, Romashkin S, Perlstein R, Burke L, Parks M. Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol A Biol Sci Med Sci. 2009 Apr; 64(4):487-91.
Score: 0.019
-
Pineau BC, Paskett ED, Chen GJ, Espeland MA, Phillips K, Han JP, Mikulaninec C, Vining DJ. Virtual colonoscopy using oral contrast compared with colonoscopy for the detection of patients with colorectal polyps. Gastroenterology. 2003 Aug; 125(2):304-10.
Score: 0.013